Clinical Trial Update: Efficacy and Tolerability of an Intra-Nasal Testosterone Product [Phase 2]

View source ↗

Summary

Phase 2 trial update on efficacy and tolerability of an intra-nasal testosterone product for hypogonadism; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Intra-Nasal Testosterone Product (unspecified)

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2018-08-13